What Microplastics Testing Proves and Where It Stops

Written by: Scott Steveson, Specialist

Key Takeaways

• Microplastics testing can reliably detect particles within validated size ranges, but a non-detect result never proves complete absence of plastic.

• Current spectroscopy methods cannot measure particles below 20–50 µm, so the nanoplastic range remains beyond reliable commercial detection.

• Independent verification against published criteria turns raw lab data into defensible, scope-locked claims that retailers and regulators can trust.

• Verification ties every claim to the tested particle-size range, polymer panel, and production period, which prevents over-extension of single-lot results.

• Brands that want credible plastic-reduction messaging can turn existing laboratory data into approved claims through the Wellness Quality Institute’s Plastic-Free Pathway Verification program.

The Core Gap Between Testing and Defensible Claims

The Wellness Quality Institute exists because a gap separates what microplastics testing can prove from what brands often claim. Self-reported laboratory results carry a built-in credibility ceiling. When a brand publishes its own test data, the market treats it as marketing, even when the testing was rigorous and expensive.

A lab report in a folder represents real work and real money. It still does not tell a skeptical retailer, procurement team, or litigator exactly what that result supports. As a result, genuine progress often goes uncommunicated. Legal teams hesitate to approve claims they cannot defend. Marketing teams soften or overreach because they lack clear boundaries. The gap between real data and a defensible market claim stays open.

Problem 1: Claims That Outpace Evidence

Many plastic-related claims move faster than the evidence behind them. A single clean result can turn into sweeping language on packaging, in press releases, and in sales decks. That pattern erodes trust and exposes brands to greenwashing risk.

Solution: Independent Review Turns Data into Approved Language

The Wellness Quality Institute is an independent verification body that reviews companies’ existing third-party laboratory data on plastic and microplastic content against a defined standard. This process supports honest progress toward plastic-reduction and plastic-free standards instead of impossible zero-plastic promises.

The Wellness Quality Institute’s core program, Plastic-Free Pathway Verification (PFPV), is governed by the standard WQI-CS-01. The program reviews a company’s laboratory dataset, testing methodology, product scope, and supporting controls against published criteria. Each review ends in one of two outcomes. A Standard Met decision provides a verification decision, a scope-locked license to use the WQI mark, a public registry listing, and approved claim language. A Standard Not Met decision remains private and can be resubmitted with updated information. Verification does not certify zero plastic; it confirms that the company is on a verified pathway toward plastic-free standards within the tested scope.

See how independent review converts your existing lab reports into defensible claims. Talk to the Wellness Quality Institute about Plastic-Free Pathway Verification.

Problem 2: Method Limits of Current Spectroscopy

Even when brands avoid overclaiming, the test methods themselves set hard limits on what any result can prove. These limits rarely appear in marketing language, yet they shape every claim.

The two most widely used techniques for microplastics in water are Raman spectroscopy and infrared (IR) spectroscopy. These methods identify polymer types by their spectral fingerprints, which function as chemical signatures for each plastic type. Both methods have validated detection ranges that stop well above the smallest particles regulators include in microplastics definitions.

The California State Water Board’s drinking-water microplastics framework is one of the most stringent public references available for this type of testing. It defines microplastics as solid polymeric material with particles that have at least three dimensions greater than 1 nanometer and less than 5,000 micrometers. Its two published analytical methods cover a much narrower window. SWB-MP1-rev1, an infrared method, is validated for particles greater than 50 µm through 5,000 µm. SWB-MP2-rev1, a Raman method, is validated for particles greater than 20 µm through 5,000 µm. ISO 16094-2, published in September 2025, provides guidance on Raman spectroscopy for microplastic analysis in water.

The gap between the regulatory definition and what any validated method can reliably detect is substantial. California’s framework reaches down to 1 nanometer, while the best validated methods begin at 20 or 50 micrometers, which are thousands of times larger. A 2026 review by Snigirova et al. in Frontiers in Environmental Science surveyed microplastics-related standards worldwide. That review confirms two unvalidated zones. The 1–20 µm fraction falls below both California methods. Everything below 1 µm, the nanoplastic range, remains beyond reliable commercial measurement.

Platform configuration also affects what a test can see. Instrument choice can materially change detection limits. A result is only as meaningful as the method and configuration that produced it.

Solution: Verification Clearly Bounds Claims to Validated Ranges

The standard WQI-CS-01 requires that every verification decision stay tied to the specific tested particle-size range and the validated method used. A Standard Met outcome does not establish absence of plastic below the method floor, outside the tested range, or outside the reviewed polymer panel. This scope lock protects both the brand and the buyer. It limits the claim to what the data can actually support, which is the foundation of defensibility.

Problem 3: Misreading “None Detected” Results

The method limits described above create a second problem. The phrase “no microplastics detected” often gets misread as proof of absence, when it actually describes what one instrument found, using one method, on one production lot, above a specific detection floor, for a defined list of polymer types.

A non-detect result in microplastics testing reflects the combined limits of the assay, sample-preparation losses, and background contamination rather than proof that particles are completely absent from the original sample. The contamination issue has been quantified. A 2023 meta-analysis of procedural blanks across the microplastics literature found that blanks intended to be zero contained 7–511 particles, with a mean of about 80. This finding suggests that many published non-detect or low-count results may reflect uncorrected laboratory background rather than true absence. Procedural blanks are control samples run alongside real samples to measure how much contamination the testing process itself introduces. When blank data is missing or inadequate, a non-detect result cannot be interpreted with confidence.

Intercomparison studies also show high variation across laboratories testing identical samples. This variation means the field currently supports reliable qualitative presence claims more readily than claims of complete absence.

Solution: Verification Demands Reporting Limits and Full Method Context

The Wellness Quality Institute review looks at the full dataset against defined requirements. These include laboratory qualification, analytical method, product matrix, sampling protocol, tested particle-size range, target polymer panel, reporting limits, blank results, spike recoveries, replicates, chain of custody, data recency, and product scope. Many companies learn for the first time what their existing data does and does not prove. That clarity includes where a “none detected” result reflects the method’s detection floor rather than the product itself.

Problem 4: No Shared Standard for Plastic-Related Claims

Without a common yardstick, every brand’s plastic claim stands alone. A retailer that receives supplier data from ten companies cannot compare those results in a meaningful way. Each dataset may use a different method, a different laboratory, a different particle-size range, and a different polymer panel. Current microplastics standards focus on detection, quantification, and characterization protocols and do not provide frameworks or thresholds for substantiating absence claims in consumer products or environmental samples.

In 2026, the EPA omitted microplastics from the proposed Unregulated Contaminant Monitoring Rule list and cited the need for more research, with the next opportunity to add them five years away. No U.S. federal standard currently exists that a brand can reference for plastic-related absence claims.

Solution: WQI-CS-01 Creates a Practical, Checkable Yardstick

The standard WQI-CS-01 provides defined, published review criteria aligned with the California State Water Board’s drinking-water microplastics reference framework, which is one of the most stringent public references reasonably applicable to testing today. The standard specifies a minimum target polymer panel, required reporting categories, defined particle-size fractions, and laboratory qualification tiers. This structure gives both brands and buyers a shared, checkable yardstick where none previously existed. California did not create, approve, authorize, or endorse the Wellness Quality Institute or its standard. The California framework functions as a technical reference point, not a geographic boundary, and verification is available to U.S. companies nationally.

Problem 5: Overclaiming from Single-Lot Results

Most plastic-related claims in the market rest on a single production lot tested under one method on one date. That single result often gets extended across a product line and over time. This pattern turns credible data into a greenwashing liability.

A 2026 review in Frontiers in Water notes that microplastics research still faces a lack of standardized sampling procedures and limited adoption of common quality-control measures. These conditions make lot-to-lot variability a persistent challenge. A clean result on one production lot does not guarantee the next lot will match it.

Solution: Scope Lock Ties Claims to Defined Evidence

Every verification decision from the Wellness Quality Institute is bound to a defined Verification Scope. That scope includes the specific product, model or SKU, product matrix, production or sampling period, analytical method, tested particle-size range, target polymer panel, reporting limits, and supporting controls. This structure prevents the single-lot overclaiming described above. No company-wide or product-line claim may be extended from a single dataset.

To enforce this boundary, claims that extend beyond the registered scope are prohibited under WQI-CS-01. Violations may result in suspension, withdrawal of verification, registry status change, and termination of mark-use rights. The verification period lasts 24 months from the sampling date of the most recent accepted dataset. After that point, continued claim use requires re-verification using current data, which keeps claims tied to present-day production.

Avoid overclaiming risk by locking your claims to verified scope. Learn how the Wellness Quality Institute’s verification process works.

Problem 6: Confusion Between Detection and Health Harm

Beyond extending claims across production lots, another common overreach involves health language. The most serious leap occurs when detection of microplastics in human tissue gets presented as proof of harm. That leap turns legitimate concern into unsupportable fear-based marketing.

Multiple recent systematic reviews confirm that scientists can detect micro- and nanoplastics in human tissues. A 2026 systematic review by Edet et al. examined the presence of micro- and nanoplastics in human tissues and concluded that further research is required to establish causal relationships in humans. A 2026 systematic review by Tran et al. in Environmental Health found that observed associations between microplastic burden and health outcomes should not be interpreted as evidence of causation.

A related distinction involves chemical additives carried by some plastics, such as phthalates and bisphenols. These substances are well established as endocrine-disrupting compounds, with evidence from animal models, human clinical observation, and epidemiology, as documented in an Endocrine Society Scientific Statement. That evidence base is far more mature than the evidence for physical microplastic particles themselves. These are connected but separate questions. Content that borrows the confidence of the additive evidence to make claims about particles alone overstates what the science currently supports.

The World Health Organization’s 2019 assessment, Microplastics in Drinking-Water, reported low concern for three potential hazard routes on the limited evidence available. The report also stressed that this conclusion rests on incomplete information and that more research is urgently needed.

Solution: Verification Keeps Detection Separate from Health Claims

The standard WQI-CS-01 prohibits health-outcome claims for verified products. Verification addresses only what the reviewed dataset supports within the tested particle-size range and polymer panel. It does not interpret those findings as proof of safety or harm for human health. That boundary protects both brands and consumers and helps ensure that positive findings remain trustworthy.

Why Independent Verification Outperforms Raw Data Alone

The six problems above are different faces of the same issue. Testing alone cannot carry the weight of market claims without clear rules, shared standards, and independent interpretation. The comparison below shows how raw lab reports, internal interpretations, supplier statements, and independent verification differ across four key dimensions.

Dimension	Raw Lab Report	Internal Interpretation	Supplier Statement	WQI Independent Verification
Independence	None, produced by a laboratory hired by the brand, with no independent review of what the result supports	None, the brand assesses its own data, and self-reported results are structurally discounted as marketing regardless of rigor	None, the supplier has a commercial interest in the outcome	Full, WQI has no commercial interest in the result, does not perform the testing it reviews, and publishes its criteria under WQI-CS-01
Transparency	Limited, the report exists but its scope, method limits, and reporting floors are rarely communicated to buyers	Variable, transparency depends entirely on what the brand chooses to disclose	Low, supplier claims typically lack method documentation, blank data, or reporting limits	High, every Standard Met product receives a public registry entry recording product scope, tested particle-size range, polymer panel, reporting limits, laboratory accreditation, and verification dates
Repeatability	Low, variation observed in intercomparison studies across laboratories means a single lab result is not automatically reproducible	Not applicable, internal interpretation is not a reproducible analytical process	Low, no standardized method or quality-control framework underpins most supplier claims	Structured, WQI-CS-01 defines required method, blank controls, spike recoveries, replicates, and chain of custody, with re-verification every 24 months against current production
Claim defensibility	Low, a number without independent review of what it supports, and non-detect results require reporting limits and qualifier codes to be interpretable	Low, the brand grades its own homework and no external party stands behind the interpretation	Low, no independent party, no published criteria, and no registry entry	High, scope-locked approved claim language, a public registry ID that any buyer or journalist can check, and prohibited-claims rules defined in WQI-CS-01

Frequently Asked Questions

The six problems above raise practical questions for brands that hold lab data and want to communicate real progress without overclaiming. The answers below address the questions the Wellness Quality Institute hears most often from companies reviewing their existing data.

What does the Wellness Quality Institute Plastic-Free Pathway Verification actually prove?

Plastic-Free Pathway Verification proves that a company’s third-party laboratory dataset was independently reviewed against the Wellness Quality Institute’s standard WQI-CS-01. It confirms that the dataset met all applicable technical and data-quality requirements within the tested particle-size range, polymer panel, and production period reviewed. It does not prove that the product contains zero plastic, microplastics, or nanoplastics. No laboratory today can confirm complete absence of plastic across every particle size, polymer type, and production lot. That limit reflects current science, not a lack of diligence. The mark “WQI Plastic-Free Pathway Verified” describes a company on a verified pathway toward plastic-free standards, not a product that has already reached a plastic-free state.

How is verification different from certification or testing?

Testing is the work a qualified independent laboratory performs. The lab analyzes a sample and reports what it found within the method’s validated range. Certification suggests a settled, guaranteed state, which current science cannot support for plastic-free status. Verification is the role the Wellness Quality Institute plays. WQI independently reviews an existing dataset against a published standard and issues a decision about what that data supports. The Wellness Quality Institute does not run laboratory tests and does not describe this program as certification. That distinction separates claims the evidence can carry from claims it cannot.

What evidence does a company typically need to submit for review?

A company submits its independent laboratory dataset along with method documentation, product scope definition, and supporting controls. The Wellness Quality Institute assesses laboratory qualification, the analytical method and its suitability for the product matrix, the tested particle-size range, the polymer panel, reporting limits, blank results, spike recoveries, replicates, chain of custody, data recency, and the production or sampling period. Companies can submit the data they already hold. The review then identifies what that dataset does and does not support.

How should a company interpret the scope and limitations of a verification decision?

A Standard Met outcome stays locked to the reviewed product, SKU, product matrix, production or sampling period, tested particle-size range, polymer panel, and analytical method. It does not establish absence of plastic below the method floor, outside the tested range, outside the reviewed polymer panel, below the reporting limit, outside the registered product scope, or outside the registered production period. Approved claim language ties directly to the specific Verification Scope record, which appears in the Wellness Quality Institute registry with a registry ID. No company-wide or product-line claim may be extended from a single dataset. A Standard Not Met outcome remains private, carries no public claim or registry listing, and may reflect insufficient data, an unsupported method, or incomplete scope rather than a problem with the product itself. The company may resubmit with corrected or additional information.

Does the Wellness Quality Institute verification replace a company’s own legal or advertising-claims review?

Verification does not replace a company’s legal or advertising-claims review. Companies remain responsible for ensuring that all product, packaging, and marketing claims are accurate and properly substantiated under applicable law. The Wellness Quality Institute verification is an independent review of a dataset against a defined standard. It is not legal, regulatory, or advertising-claims counsel. The Wellness Quality Institute provides a press kit with approved headline options, quote templates, badge language, and explicit lists of claim language to use and avoid. Company legal and compliance teams still decide how claims appear in market.

Turning Existing Data into Claims a Brand Can Stand Behind

Testing shows what a validated method found within its detection range for the polymer types it screened on the production lot it sampled. That information is valuable, yet it does not automatically become a defensible market claim. A lab report and an independently reviewed claim are different tools, and the market treats them differently.

For U.S. brands that already hold third-party laboratory data, independent review of that dataset against defined criteria offers a practical route from report to defensible language. Independent review against WQI-CS-01, the standard introduced earlier, provides published criteria that brands and buyers can check. A single assessment fee covers review, verification decision, and registry listing. Independent laboratory testing is arranged and billed separately by a qualified independent laboratory, and payment of the assessment fee does not guarantee a verification decision.

The honest position in this field acknowledges that plastics are present, effectively unavoidable, and worth understanding. It also recognizes that the measurement tools, standards, and claim frameworks needed for a serious public conversation are still under construction. Brands making genuine progress deserve a credible way to show it. Independent review against a defined standard offers one practical route to that demonstration, using data many companies already have.

WQI Plastic-Free Pathway Verification does not certify that a product contains zero plastic, microplastics, or nanoplastics. It shows that the company is on a verified pathway toward plastic-free standards. Verification applies only to the reviewed products, submitted datasets, tested ranges, polymer panels, production or sampling periods, and supporting controls. WQI verification is not a California approval, government certification, or health or safety certification.

Turn real lab data into a claim you can support. Talk to the Wellness Quality Institute about Plastic-Free Pathway Verification.